FDA Enforcement Office Director Niedelman Brings CDRH Background To Post
Executive Summary
The FDA Office of Enforcement's transition to "risk-based" good manufacturing practices oversight will be led by an FDAer with more than two decades of experience in medical device manufacturing regulation